Capital Fund Management (CFM)
USNA icon

Capital Fund Management (CFM)’s Usana Health Sciences USNA Stock Holding History

Capital Fund Management (CFM)’s Portfolio USNA Stock Details USNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-5,200
Closed -$436K – 1943
2019
Q1 		$436K Buy
5,200
+3,100
+148% +$324K ﹤0.01% 1298
2018
Q4 		$247K Sell
2,100
-1,200
-36% -$139K ﹤0.01% 1675
2018
Q3 		$398K Sell
3,300
-800
-20% -$99.3K ﹤0.01% 1678
2018
Q2 		$473K Buy
+4,100
New +$449K ﹤0.01% 1619
2015
Q2 		– Sell
-4,600
Closed -$256K – 1715
2015
Q1 		$256K Buy
+4,600
New +$236K ﹤0.01% 1300
2014
Q2 		– Sell
-14,884
Closed -$561K – 1952
2014
Q1 		$561K Buy
+14,884
New +$520K 0.01% 1195
2013
Q3 		– Sell
-7,600
Closed -$275K – 1918
2013
Q2 		$275K Buy
+7,600
New +$231K ﹤0.01% 1166

Other funds holding USNA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
JIM
Jupiter Investment Management London, United Kingdom $6.26B AUM 13.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Capital Fund Management (CFM)'s USNA Position: Q2 2019 in Review

Capital Fund Management (CFM) sold out of Usana Health Sciences (USNA) in Q2 2019, closing a stake of 5,200 shares — an estimated $436K sold.

Capital Fund Management (CFM) first reported a position in USNA in Q2 2013 and held it in 7 quarters. The position peaked at $561K in Q1 2014. 173 funds tracked by Wall St. Rank hold USNA as of Q2 2019.

  • Capital Fund Management (CFM) reported no remaining Usana Health Sciences position as of Q2 2019 after selling out during the quarter.
  • Capital Fund Management (CFM) sold 5,200 Usana Health Sciences shares in Q2 2019, an estimated $436K.
  • Capital Fund Management (CFM) first reported a position in Usana Health Sciences in Q2 2013 and held it in 7 quarters.
  • Capital Fund Management (CFM)'s Usana Health Sciences position peaked at $561K in Q1 2014.
  • 173 funds tracked by Wall St. Rank held Usana Health Sciences as of Q2 2019.

Based on Capital Fund Management (CFM)'s 13F filing for Q2 2019, filed 12 Aug 2019.